Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.

Jaiswal, Anil Kumar

Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target. [electronic resource] - International journal of antimicrobial agents Dec 2016 - 695-702 p. digital

Publication Type: Journal Article

1872-7913

10.1016/j.ijantimicag.2016.09.018 doi


Animals
Antiprotozoal Agents--administration & dosage
Cell Line
Chalcone--administration & dosage
Cricetinae
DNA, Protozoan--genetics
DNA, Ribosomal--genetics
Disease Models, Animal
Drug Evaluation, Preclinical--methods
Female
Flow Cytometry--methods
Genes, Reporter
Hydrazones--administration & dosage
Leishmania donovani--drug effects
Leishmaniasis, Visceral--drug therapy
Luminescent Proteins--analysis
Macrophages--parasitology
Male
Mice
RNA, Ribosomal, 18S--genetics
Recombination, Genetic
Staining and Labeling--methods
Treatment Outcome